Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis‐trans isomerase in a secretagogue specific manner
- 1 August 1992
- Vol. 47 (4) , 353-361
- https://doi.org/10.1111/j.1398-9995.1992.tb02071.x
Abstract
Bergstrand H, Lundquist B. Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis‐trans isomerase in a secretagogue specific manner.To assess the role of calmodulin in human basophil histamine release, we triggered leukocytes with different secretagogues in the presence of putative inhibitors of calmodulin. Calcium ionophore‐induced histamine release was reduced or blocked by calmidazolium, CGS 9343B, felodipine, metofenazate, and Ro 22–4839. H 186/86, a felodipine‐related dihydropyridine derivative, blocked A23187‐but not ionomycin‐triggered histamine release, suggesting a difference in the mode of action of these ionophores. In contrast, leukocyte histamine release triggered by the purported protein kinase C (PKC) activator, l, 2‐isopropylidene‐3‐decanoyl‐sn‐glycerol (IpOCOC9), was enhanced by calmidazolium, CGS 9349B and metofenazate but not affected by felodipine or Ro 22‐4839, whereas the response triggered by 4β‐phorbol 12‐myristate 13‐aeetate (PMA) was reduced by metofenazate and Ro 22‐4839 but not consistently affected by calmidazolium, CGS 9343B or felodipine. The PMA‐induced histamine release was enhanced by H 186/86. Anti‐IgE‐ and Fmlp‐induced responses were either unaffected or slightly enhanced by the examined calmodulin antagonists. In comparison with the calmodulin antagonists, R 59022, an inhibitor of diacylglycerol kinase, failed to reduce calcium ionophore‐triggered histamine release, whereas FK506, an inhibitor of peptidyl prolyl cis‐trans isomerase (PPI), reduced both anti‐IgE‐ and ionophore‐triggered responses. These results indicate that calmodulin constitutes an obligate link in signal transduction pathways leading to human leukocyte histamine release if the trigger is a calcium ionophore but not when responses are induced by anti‐IgE, Fmlp or PMA; a calmodulin‐dependent component may rather balance responses induced by IpOCOC9. We also conclude that most employed stimuli, including IpOCOC9, trigger human basophil histamine release through partly distinet pathways.Keywords
This publication has 48 references indexed in Scilit:
- Polymyxin B is a selective and potent antagonist of calmodulinEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- The biology and clinical applications of interleukin 2Immunology Today, 1990
- FK-506 enters the clinicImmunology Today, 1990
- CyclosporineNew England Journal of Medicine, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Diacylglycerol kinase inhibitors R59022 and dioctanoylethylene glycol potentiate the respiratory burst of neutrophils by raising cytosolic Ca2+Biochemical and Biophysical Research Communications, 1989
- The inhibition of arachidonic acid mobilization in human platelets by R59 022, a diacylglycerol kinase inhibitorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Differential effects of the diacylglycerol kinase inhibitor R59022 on thrombin versus collagen-induced human platelet secretionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988
- Specific inhibition of phorbol ester and DiC8-induced histamine release from human basophils by the protein kinase C inhibitors, H-7 and H-9Biochemical and Biophysical Research Communications, 1987
- Possible role of calmodulin in the control of histamine release from human basophil leukocytesLife Sciences, 1986